NCT03589729
- Conditions
- Acute Myeloid Leukemia, Blast Crisis, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, +25 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Explore clinical trials studying Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive. Study availability and eligibility vary by location and protocol.
18 public trials
4 recruiting studies
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive trial results
NCT03263572
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein Expression, +29 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT02115295
- Conditions
- Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Crisis, +36 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT03630991
- Conditions
- Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Blast Crisis, +35 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia
NCT03147612
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia With BCR-ABL1, +27 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
Hu8F4 in Treating Patients With Advanced Hematologic Malignancies
NCT02530034
- Conditions
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Blast Crisis, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, +31 more
- Locations
-
- Augusta University Augusta, Georgia, United States
- Montefiore Medical Center, Albert Einstein College of Medicine The Bronx, New York, United States
- M D Anderson Cancer Center Houston, Texas, United States
- Huntsman Cancer Institute Salt Lake City, Utah, United States
Active, not recruiting
Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia
NCT01424982
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic Leukemia in Complete Remission, +28 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT04188405
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Crisis, +23 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT02220985
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage, +57 more
- Locations
-
- University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00390793
- Conditions
- Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein Expression, Blast Crisis, +26 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States